Physician profile
Ewa Osolkowski
NPI 1174637326
$2,893.06
in general payments reported to CMS, 2019-2025
16 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,456 · 2020: $41.10 · 2021: $425 · 2023: $318 · 2024: $271 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $971.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $970.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $727.18 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $689.07 | 2019-2025 | Jardiance |
| Janssen Pharmaceuticals, INC | $252.07 | 2019-2021 | |
| Glaxosmithkline, LLC. | $211.82 | 2019-2024 | Arexvy, Shingrix |
| Merck Sharp & Dohme LLC | $183.45 | 2024-2025 | Capvaxive, Gardasil 9, M-M-R II |
| Novartis Pharmaceuticals Corporation | $171.54 | 2019-2023 | |
| Amgen INC. | $160.02 | 2019-2024 | Prolia, Evenity |
| Gilead Sciences, INC. | $144.92 | 2023-2025 | Livdelzi, Vemlidy |
| E.R. Squibb & Sons, L.L.C. | $109.77 | 2019-2024 | Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $63.01 | 2024 | |
| Exact Sciences Corporation | $55.18 | 2024-2025 | Cologuard Collection Kit |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $38.04 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $24.79 | 2024 | Farxiga |
| Sanofi-Aventis U.S. LLC | $23.27 | 2021 | |
| Pfizer INC. | $21.89 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $17.04 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ewa Osolkowski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.